These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19578390)

  • 21. Anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis: bayes clears the haze.
    Finckh A; Liang MH
    Ann Intern Med; 2007 Jun; 146(11):816-7. PubMed ID: 17548414
    [No Abstract]   [Full Text] [Related]  

  • 22. Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis.
    Zendman AJ; Vossenaar ER; van Venrooij WJ
    Autoimmunity; 2004 Jun; 37(4):295-9. PubMed ID: 15518045
    [No Abstract]   [Full Text] [Related]  

  • 23. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibodies against citrullinated peptides in clinical practice and research].
    Engelmann R; Müller-Hilke B
    Z Rheumatol; 2009 Aug; 68(6):485-90. PubMed ID: 19578861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.
    Alivernini S; Galeazzi M; Peleg H; Tolusso B; Gremese E; Ferraccioli G; Naparstek Y
    Autoimmun Rev; 2017 Nov; 16(11):1096-1102. PubMed ID: 28899798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
    Ajeganova S; Humphreys JH; Verheul MK; van Steenbergen HW; van Nies JA; Hafström I; Svensson B; Huizinga TW; Trouw LA; Verstappen SM; van der Helm-van Mil AH
    Ann Rheum Dis; 2016 Nov; 75(11):1924-1932. PubMed ID: 26757747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis.
    Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis.
    Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Tafaj A; Izairi R; Rexhepi B
    Reumatizam; 2011; 58(1):12-4. PubMed ID: 21751570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
    Bertin D; Dubucquoi S; Lakomy D; Deleplancque AS; Desplat-Jégo S
    Immunol Res; 2016 Apr; 64(2):455-60. PubMed ID: 26350265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    van Venrooij WJ; van de Putte LB
    Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis.
    Gerli R; Bartoloni Bocci E; Sherer Y; Vaudo G; Moscatelli S; Shoenfeld Y
    Ann Rheum Dis; 2008 May; 67(5):724-5. PubMed ID: 18408112
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis].
    Erre GL; Tocco A; Faedda R; Cossu A; Carcassi A
    Reumatismo; 2004; 56(2):118-23. PubMed ID: 15309221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of autoantibodies to post-translationally modified proteins to inflammatory arthritis.
    van der Woude D; Toes RE
    Curr Opin Rheumatol; 2017 Mar; 29(2):195-200. PubMed ID: 27977623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Roubenoff R; Beckman E; Weinblatt M; Shadick N; Gregersen PK
    Ann Intern Med; 2008 Mar; 148(5):403; author reply 403-4. PubMed ID: 18316760
    [No Abstract]   [Full Text] [Related]  

  • 37. Biological significance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis.
    Arkfeld DG
    Ann Intern Med; 2008 Mar; 148(5):403; author reply 403-4. PubMed ID: 18316759
    [No Abstract]   [Full Text] [Related]  

  • 38. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

  • 39. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
    Coenen D; Verschueren P; Westhovens R; Bossuyt X
    Clin Chem; 2007 Mar; 53(3):498-504. PubMed ID: 17259232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.